Tumor size and survival in multicentric and multifocal breast cancer-Reference-Cited by-同舟云学术

Tumor size and survival in multicentric and multifocal breast cancer

Published:2011-06 Issue:3 Volume:20 Page:259-263
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Rezo Angela,Dahlstrom Jane,Shadbolt Bruce,Rodins Karl,Zhang Yanping,Davis Alison J.

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference25 articles.

1. Synchronous multiple ipsilateral breast cancers: implications for patient management;Jain;Pathology,2009

2. Pathology of the breast;Tavassoli,1999

3. Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis;Noguchi;Cancer,1994

4. Discrimination between multicentric and multifocal breast carcinoma by cytogenetic investigation of macroscopically distinct ipsilateral lesions;Teixeira;Genes Chromosomes Cancer,1997

5. Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q;Tsuda;Cancer Res,1995

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Técnica de la biopsia selectiva del ganglio centinela en tumores multifocales de la mama;Revista de Senología y Patología Mamaria;2024-04

2. A retrospective comparative cohort study of SEER database analysis of the prognostic value of breast-conserving surgery and mastectomy in patients with multifocal multicenter breast cancer;Gland Surgery;2023-02

3. Survival, Recurrence, and Clinicopatho- logical Characteristics in Multifocal and/or Multicentric versus Unifocal Locoregional Breast Cancers: Results of a Large Breast Cancer Registry;MIDDLE EAST J CANCER;2023

4. Comparing the outcome between multicentric/multifocal breast cancer and unifocal breast cancer: A systematic review and meta-analysis;Frontiers in Oncology;2022-12-16

5. Volatile Organic Compounds Analysis as a Potential Novel Screening Tool for Breast Cancer: A Systematic Review;Biomarker Insights;2022-01